abu-dhabi-seascape-with-skyscrapers

Stem cell therapy
in the UAE

Responsible access to high quality mesenchymal stem cells through a clinical study program.  Approved by the Department of Health and Ministry of Health and Prevention.

This is a local, patient-funded, clinical trial sponsored by Cellcolabs Clinical SPV Limited

Trials

Explore our trials

Treatment administration follows our therapy protocol based on the specific indication.

Osteoarthritis (Phase II Clinical Study)

Osteoarthritis (OA) is one of the most common joint conditions worldwide, limiting movement,
daily activities, and independence. 

Administration:
Ultrasound-guided injection into a joint

Typical dose:
50 million MSCs per joint

Eligibility:
Adults 18+ | Diagnosed with grade I-IV knee osteoarthritis

Targeted joint delivery:
In intra-articular (IA) treatment, mesenchymal stem cells are injected directly into a joint,
concentrating the treatment on a specific area.

Follow-up:
Clinical follow-ups at 3, 6 and 12 months

*Please note participation is self-funded.

Care. Simplified.

Clinical guidance when you need it.
Dedicated Participant Advocate guides you through your VIP stem cell journey and helps you with treatment questions and practical information.

Seamless logistics & travel support.
Our exclusive partnership with an elite travel Concierge arranges flight, hotels, chauffeur services for your convenience to make your premium visit effortless.

Mishkat Shehata new

Mishkat Shehata

D.O

Nastaran Shekary new

Nastaran Shekary

Director of Clinical Partnerships

Monika Sharma

Monika Sharma

Head of Scientific & Clinical Operations

nina.leibenfrost-1

Nina Leibenfrost

Head of Partnerships

Philippa D lw(1 of 1)

Philippa Dismorr

Partnership Manager

Cellcolabs Bahar UAE

Bahar Kasaei

Participant Advocate

Meet the team

Our medical team are globally recognized experts in regenerative medicine, orthopedics, and stem cell research.

Meet the entire team ↗

Personal guidance

Start your journey with a complimentary consultation

Step into the trial.

1

Register your interest

Register here through our study website to receive more information.

2

Consultation

You will be invited to book an online session with our Participant Advocate. During this session, you will receive a clear overview of the treatment and study process, and we will review your eligibility.

3

Confirmation

If you meet the pre-screening criteria, you will receive a formal offer to participate. Once accepted, your treatment date will be scheduled.

4

Screening and treatment

The study physician will carry out a thorough assessment with comprehensive imaging to confirm the suitability of this treatment for you.

5

Follow-up meetings

You will take part in scheduled follow-up assessments to monitor health and track outcomes. Teleconsultations are available for your convenience.

Our clinics

Treatments are conducted in partner clinics that prioritize privacy, calm surroundings and patient confidentiality.

Burjeel Medical City

Burjeel Medical City provides a world-class clinical environment designed to deliver advanced, internationally accredited care. Located in Abu Dhabi, it offers a modern, private, and highly specialized setting trusted by patients from across the region and abroad.
Get directions
Our production

Manufactured in Sweden.Delivered worldwide.

Every Cellcolabs Clinical dose begins in our EU-GMP certified facility in Sweden and is safeguarded through GDP-regulated transport. Across all clinics, physicians follow one unified global protocol. The result is consistent quality and clinically responsible care wherever treatment is delivered.

Get in touch with the UAE team

Participant Advocate Number
+971509157776

The clinical study program includes:

  1. Ultrasound Guided Mesenchymal Stem Cell therapy for knee Osteoarthritis
  2. Specialist consultation with our leading orthopedic expert
  3. Comprehensive radiology assessments
  4. Structured follow-up program over 12 months
  5. VIP lounge and suite booking as part of your journey